Filippo Acconcia

Filippo Acconcia

Sep 19, 2017

Group 6 Copy 13
1
Please wait...

About This Project

70% of breast cancers are estrogen receptor α (ERα)-positive. ERα is the antenna that senses the ovarian hormone estrogen (E2) and drives tumour cell proliferation and spreading. 4OH-tamoxifen and faslodex are given to patients to prevent cancer growth and spreading but they possess serious side effects. Thus, additional drugs are needed to fight breast cancer. We will explore existing drugs for the possibility of ‘reuse’ as breast cancer drugs.

Blast off!

Browse Other Projects on Experiment

Related Projects

Can Data Management Tools Improve Research Efficiency and Reproducibility?

Scientists are generating data at unprecedented rates, but our data management methods have yet to evolve accordingly...

A Leap Forward to Cure a Neglected Disease

The World Health Organization estimates that as many as 11 million people worldwide are infected with the parasite...

What's Calcium's role in heart and kidney disease?

Hardening of the arteries, or atherosclerosis, is a global problem leading to heart attacks and strokes. Many...

Campaign Ended